MY184493A - Phytoestrogenic compositions for preventing or treating symptoms associated with menopause - Google Patents

Phytoestrogenic compositions for preventing or treating symptoms associated with menopause

Info

Publication number
MY184493A
MY184493A MYPI2011002681A MYPI2011002681A MY184493A MY 184493 A MY184493 A MY 184493A MY PI2011002681 A MYPI2011002681 A MY PI2011002681A MY PI2011002681 A MYPI2011002681 A MY PI2011002681A MY 184493 A MY184493 A MY 184493A
Authority
MY
Malaysia
Prior art keywords
preventing
menopause
phytoestrogenic
compositions
symptoms associated
Prior art date
Application number
MYPI2011002681A
Inventor
Jae-Soo Kim
Bo-Yeon Kwak
Kwontaek Yi
Jaekyoung Lee
Original Assignee
Natural Endotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natural Endotech Co Ltd filed Critical Natural Endotech Co Ltd
Publication of MY184493A publication Critical patent/MY184493A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a pharmaceutical composition for preventing or treating a menopausal disorder, comprising cinnamic acid, shanzhiside methylester or a mixture thereof as an active ingredient. The composition of the present invention exhibits an excellent estrogenic activity, and is effectively utilized for treating or preventing diverse menopausal disorders generated by estrogen reduction during perimenopause, menopause and postmenopause.
MYPI2011002681A 2008-12-26 2008-12-26 Phytoestrogenic compositions for preventing or treating symptoms associated with menopause MY184493A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2008/007697 WO2010074361A1 (en) 2008-12-26 2008-12-26 Phytoestrogenic compositions for preventing or treating symptoms associated with menopause

Publications (1)

Publication Number Publication Date
MY184493A true MY184493A (en) 2021-04-01

Family

ID=42287937

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2011002681A MY184493A (en) 2008-12-26 2008-12-26 Phytoestrogenic compositions for preventing or treating symptoms associated with menopause

Country Status (12)

Country Link
US (1) US9433595B2 (en)
EP (1) EP2370072B1 (en)
CN (1) CN102264362B (en)
AU (1) AU2008365666B2 (en)
BR (1) BRPI0823391B8 (en)
CA (1) CA2745020C (en)
ES (1) ES2641291T3 (en)
MX (1) MX2011005835A (en)
MY (1) MY184493A (en)
PL (1) PL2370072T3 (en)
RU (1) RU2491926C2 (en)
WO (1) WO2010074361A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101698051B1 (en) * 2016-01-13 2017-01-20 아주대학교산학협력단 Composition for preventing, improving or treating female menopause symptoms comprising Loganin or its derivatives
RU2736997C1 (en) * 2019-07-30 2020-11-23 Общество С Ограниченной Ответственностью "Парафарм" Agent for treating hot flashes and recuperating menstrual cycle during perimenopause and method of using it
US12578322B2 (en) 2020-12-07 2026-03-17 Kimberly-Clark Worldwide, Inc. Methods and consumer products for detecting a metabolite
CN115671217B (en) * 2022-11-25 2023-08-01 长春中医药大学 Traditional Chinese medicine formula for treating various symptoms before and after menopause

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5874084A (en) * 1996-07-19 1999-02-23 Yng-Wong; Quing Non Using complex herbal formulations to treat hot flashes
US6660283B2 (en) * 1997-12-19 2003-12-09 Societe L'oreal S.A. Use of cinnamic acid, or of at least one of its derivatives in a cosmetic composition
FR2772612B1 (en) * 1997-12-19 2003-01-10 Oreal USE OF CINNAMIC ACID OR DERIVATIVES THEREOF IN A FIRMING COSMETIC COMPOSITION
CN1303671A (en) * 1999-11-26 2001-07-18 深圳市御康实业有限公司湖南省分公司 Application of cinnamic acid in preparation of medicine for curing diabetes
AU2000272667A1 (en) * 2000-09-13 2002-04-29 Jiangsu Kanion Pharmaceutical Co. Pharmaceutical composition treating gynecological blood stasis diseases, cardio and cerebral vascular diseases, respiratory diseases and the like
FR2823672B1 (en) * 2001-04-23 2004-03-12 Berkem Sa HOP EXTRACTS AND THEIR USE IN THE PREPARATION OF A MEDICINAL PRODUCT HAVING ESTROGENIC PROPERTIES
US6664236B2 (en) * 2002-03-19 2003-12-16 Council Of Scientific And Industrial Research Synergistic composition of bioactive fraction isolated from barleria prionitis linn and a method of treatment for hepatotoxicity, immuno-deficiency and fatigue and a process thereof
KR100740566B1 (en) * 2006-03-13 2007-07-18 경희대학교 산학협력단 Composition showing anti-anxiety and memory improvement effect comprising phenyl propanoid compound
KR20080093203A (en) * 2007-04-16 2008-10-21 경희대학교 산학협력단 Composition for the prevention and treatment of fracture diseases, containing as an active ingredient a compound selected from arginine, cinnamic acid, dydazine, puerarin, palmatin, berberine or beta-di-glucopyranoside

Also Published As

Publication number Publication date
CA2745020A1 (en) 2010-07-01
RU2011130246A (en) 2013-02-10
WO2010074361A1 (en) 2010-07-01
US20110251145A1 (en) 2011-10-13
ES2641291T3 (en) 2017-11-08
CN102264362A (en) 2011-11-30
CN102264362B (en) 2013-10-23
CA2745020C (en) 2013-10-15
EP2370072A1 (en) 2011-10-05
EP2370072B1 (en) 2017-06-28
AU2008365666A1 (en) 2011-07-07
MX2011005835A (en) 2011-07-04
BRPI0823391A2 (en) 2015-06-16
BRPI0823391B8 (en) 2021-05-25
AU2008365666B2 (en) 2013-05-23
BRPI0823391B1 (en) 2019-06-18
RU2491926C2 (en) 2013-09-10
US9433595B2 (en) 2016-09-06
PL2370072T3 (en) 2017-12-29
EP2370072A4 (en) 2012-09-05

Similar Documents

Publication Publication Date Title
PH12015501404A1 (en) Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
MX2012012026A (en) Very low-dosed solid oral dosage forms for hrt.
WO2012116290A3 (en) Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
UA105033C2 (en) Pharmaceutical composition comprising glucopyranosyl-substituted benzene derivative, pharmaceutical dosage form thereof, process for their preparation and uses thereof for treating metabolic disorders
PH12016500216A1 (en) Stable pharmaceutical composition and methods of using same
IN2012DN00639A (en)
WO2013142817A3 (en) Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
MY160074A (en) Protopanaxadiol-type ginsenoside compositions and uses thereof
MY159630A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
UA106634C2 (en) Solid pharmaceutical dosage form
NZ700195A (en) Compositions comprising deoxycholic acid
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
MX2009009153A (en) Pyrano-pyrazole-amines.
WO2008116890A3 (en) Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
WO2008052139A3 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
EP2420230A3 (en) Antiangiogenic agents
MX2011011494A (en) Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4 -benzoquinone for the treatment of primary progressive multiple sclerosis.
PH12013500293A1 (en) Methods of treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin
BR112012018765A2 (en) prophylactic or therapeutic agent for biliary tract diseases
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
BR112012022209A2 (en) pharmaceutical compositions comprising monoterpenes
MX2009001315A (en) Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments.
WO2010117346A3 (en) Stable pharmaceutical compositions with high bioavailability
WO2010123221A3 (en) Composition for preventing and improving the symptoms of menopause, containing glyceollins as an active ingredient